Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mehmet Asim Bilen"'
Autor:
Xinmeng Jasmine Mu, J.M.G. Larkin, Brian I. Rini, Keith A. Ching, Mariangela Mariani, A. di Pietro, Boris Alekseev, Aleksander Chudnovsky, Laurence Albiges, Gwenaelle Gravis, Robert J. Motzer, Bo Huang, Paul B. Robbins, Balaji Venugopal, Mehmet Asim Bilen, Sumanta K. Pal, Hideaki Miyake, Subramanian Hariharan, Toni K. Choueiri
Publikováno v:
ESMO Open
ESMO Open, 2021, 6 (3), pp.100101. ⟨10.1016/j.esmoop.2021.100101⟩
ESMO Open, 2021, 6 (3), pp.100101. ⟨10.1016/j.esmoop.2021.100101⟩
Background Among patients with advanced renal cell carcinoma (RCC), those with sarcomatoid histology (sRCC) have the poorest prognosis. This analysis assessed the efficacy of avelumab plus axitinib versus sunitinib in patients with treatment-naive ad
Autor:
Mehrdad Alemozaffar, Christopher P. Filson, Wayne Harris, Peter T. Nieh, Dattatraya Patil, Anna Bausum, Yoram Baum, Rishi R. Sekar, Kenneth Ogan, John G. Pattaras, Bradley C. Carthon, Omer Kucuk, Mehmet Asim Bilen, Jeffrey Pearl, Viraj A. Master
Publikováno v:
Asian Journal of Urology, Vol 4, Iss 4, Pp 230-238 (2017)
Asian Journal of Urology
Asian Journal of Urology
Objective Several inflammatory markers have been studied as potential biomarkers in renal cell carcinoma (RCC), however few reports have analyzed their prognostic value in aggregate and in non-clear cell histologies. We hypothesize that a combination